http://www.abbott.com Press Releases http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0799.htm?referrer=RSS The Deal Names Abbott Top Dealmaker for Second Consecutive Year Thu, 19 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0799.htm?referrer=RSS 2009-11-19T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0796.htm?referrer=RSS Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform Tue, 17 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0796.htm?referrer=RSS 2009-11-17T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0798.htm?referrer=RSS Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial Mon, 16 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0798.htm?referrer=RSS 2009-11-16T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0797.htm?referrer=RSS Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release) Sun, 15 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0797.htm?referrer=RSS 2009-11-15T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0795.htm?referrer=RSS Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain Thu, 12 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0795.htm?referrer=RSS 2009-11-12T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0794.htm?referrer=RSS New Web sites Educate about Triglycerides and HDL Cholesterol Thu, 12 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0794.htm?referrer=RSS 2009-11-12T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0791.htm?referrer=RSS President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department Tue, 03 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0791.htm?referrer=RSS 2009-11-03T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0789.htm?referrer=RSS Abbott Completes Acquisition of Evalve, Inc. Mon, 02 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0789.htm?referrer=RSS 2009-11-02T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0790.htm?referrer=RSS Abbott Saving 1 Billion Gallons of Water Annually Mon, 02 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0790.htm?referrer=RSS 2009-11-02T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0793.htm?referrer=RSS Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes Mon, 02 Nov 2009 06:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0793.htm?referrer=RSS 2009-11-02T06:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0788.htm?referrer=RSS Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois Thu, 29 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0788.htm?referrer=RSS 2009-10-29T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0786.htm?referrer=RSS FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis Tue, 20 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0786.htm?referrer=RSS 2009-10-20T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0787.htm?referrer=RSS Abbott Completes Visiogen Acquisition Tue, 20 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0787.htm?referrer=RSS 2009-10-20T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0785.htm?referrer=RSS ZonePerfect Indulgence™ Nutrition Squares Give Chocolate Lovers a Sensible Sweet-Tooth Option Mon, 19 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0785.htm?referrer=RSS 2009-10-19T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0784.htm?referrer=RSS Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009 Wed, 14 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0784.htm?referrer=RSS 2009-10-14T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0783.htm?referrer=RSS Novel Abbott Test That Aids in the Early Diagnosis of Acute Kidney Injury (AKI) Receives CE Mark Tue, 06 Oct 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0783.htm?referrer=RSS 2009-10-06T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0782.htm?referrer=RSS Abbott Cuts Use of Oil and Coal by 35 Percent Wed, 30 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0782.htm?referrer=RSS 2009-09-30T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0781.htm?referrer=RSS Abbott to Acquire Solvay Pharmaceuticals Business Mon, 28 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0781.htm?referrer=RSS 2009-09-28T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0775.htm?referrer=RSS Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease Thu, 24 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0775.htm?referrer=RSS 2009-09-24T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0778.htm?referrer=RSS Abbott Hosts Conference Call for Third-Quarter Earnings Thu, 24 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0778.htm?referrer=RSS 2009-09-24T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0774.htm?referrer=RSS Abbott's XIENCE V® Superior to TAXUS® in Key Safety and Efficacy Measures in SPIRIT IV Trial Wed, 23 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0774.htm?referrer=RSS 2009-09-23T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0779.htm?referrer=RSS Abbott's XIENCE V® Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS® Liberte in Investigator-Initiated COMPARE Trial Wed, 23 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0779.htm?referrer=RSS 2009-09-23T05:00:00Z http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0777.htm?referrer=RSS Abbott Again Honored for Offering One of the 'Top 10' Leading Workplaces Tue, 22 Sep 2009 05:00:00 GMT http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0777.htm?referrer=RSS 2009-09-22T05:00:00Z